Eight-Year Follow-Up of Neuropsychiatric Symptoms and Brain Structural Changes in Fabry Disease

被引:26
作者
Lelieveld, Irene M. [1 ]
Boettcher, Anna [1 ]
Hennermann, Julia B. [2 ]
Beck, Michael [3 ]
Fellgiebel, Andreas [1 ]
机构
[1] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Psychiat & Psychotherapy, D-55122 Mainz, Germany
[2] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Ctr Pediat & Adolescent Med, Villa Metab, D-55122 Mainz, Germany
[3] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Human Genet, D-55122 Mainz, Germany
关键词
WHITE-MATTER LESIONS; ALPHA-GALACTOSIDASE; DEPRESSION; MUTATIONS; GENE; HIPPOCAMPUS;
D O I
10.1371/journal.pone.0137603
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Brain structural alterations and neuropsychiatric symptoms have been described repeatedly in Fabry disease, yet cognitive deficits have been shown to be only mild. Here, we aimed to investigate neuropsychiatric symptoms and brain structure longitudinally. We expected no clinically relevant increase of neuropsychiatric symptoms in parallel to increased brain structural alterations. We assessed 14 Fabry patients (46.1 +/- 10.8 years) who had participated in our investigation eight years ago. Patients engaged in neuropsychiatric testing, as well as structural magnetic resonance imaging and angiography to determine white matter lesions, hippocampal volume, and the diameter of the larger intracranial arteries. While Fabry patients did not differ on cognitive performance, they showed progressive and significant hippocampal volume loss over the 8-year observation period. White matter lesions were associated with older age and higher white matter lesion load at baseline, but did not reach statistical significance when comparing baseline to follow-up. Likewise, intracranial artery diameters did not increase significantly. None of the imaging parameters were associated with the neuropsychiatric parameters. Depression frequency reduced from 50% at baseline to 21% at follow-up, but it did not reach significance. This investigation demonstrates clinical stability in cognitive function, while pronounced hippocampal atrophy is apparent throughout the 8 years. Our middle-aged Fabry patients appeared to compensate successfully for progressive hippocampal volume loss. The hippocampal volume decline indicates brain regional neuronal involvement in Fabry disease.
引用
收藏
页数:11
相关论文
共 39 条
[1]  
[Anonymous], HUM MUTAT
[2]  
[Anonymous], 1964, Lexamen Clinique en Psychologie The Clinical Psychological Examination
[3]  
[Anonymous], EUR J HUM GENET
[4]  
[Anonymous], 1979, TRAIL MAKING TEST MA
[5]  
Ashton-Prolla P, 2000, J INVEST MED, V48, P227
[6]   A meta-analysis of hippocampal atrophy rates in Alzheimer's disease [J].
Barnes, Josephine ;
Bartlett, Jonathan W. ;
van de Pol, Laura A. ;
Loy, Clement T. ;
Scahill, Rachael I. ;
Frost, Chris ;
Thompson, Paul ;
Fox, Nick C. .
NEUROBIOLOGY OF AGING, 2009, 30 (11) :1711-1723
[7]   Cognitive dysfunction and depression in Fabry disease: a systematic review [J].
Bolsover, Fay E. ;
Murphy, Elaine ;
Cipolotti, Lisa ;
Werring, David J. ;
Lachmann, Robin H. .
JOURNAL OF INHERITED METABOLIC DISEASE, 2014, 37 (02) :177-187
[8]   PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE [J].
COCKCROFT, DW ;
GAULT, MH .
NEPHRON, 1976, 16 (01) :31-41
[9]   Fabry disease, an under-recognized multisystemic disorder: Expert recommendations for diagnosis, management, and enzyme replacement therapy [J].
Desnick, RJ ;
Brady, R ;
Barranger, J ;
Collins, AJ ;
Germain, DP ;
Goldman, M ;
Grabowski, G ;
Packman, S ;
Wilcox, WR .
ANNALS OF INTERNAL MEDICINE, 2003, 138 (04) :338-346
[10]   FABRY-DISEASE - 23 MUTATIONS INCLUDING SENSE AND ANTISENSE CPG ALTERATIONS AND IDENTIFICATION OF A DELETIONAL HOT-SPOT IN THE ALPHA-GALACTOSIDASE-A GENE [J].
ENG, CM ;
NIEHAUS, DJ ;
ENRIQUEZ, AL ;
BURGERT, TS ;
LUDMAN, MD ;
DESNICK, RJ .
HUMAN MOLECULAR GENETICS, 1994, 3 (10) :1795-1799